Secondary Glaucoma after Intravitreal Dexamethasone 0.7 mg Implant in Patients with Retinal Vein Occlusion: A One-Year Follow-Up

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 6, 2013, Pages 560-565

  Meyer, Linda M ^a   Schönfeld, Carl Ludwig ^a  

^a Eye Hospital Herzog Carl Theodor   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; DRUG IMPLANTATION; FEMALE; FOLLOW UP; GOLDMANN APPLANATION TONOMETER; HUMAN; INTRACRANIAL HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETINA MACULA EDEMA; SECONDARY GLAUCOMA; TREATMENT DURATION; VISUAL ACUITY;

AGED; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TONOMETRY, OCULAR; VISUAL ACUITY;

EID: 84880212448     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0253     Document Type: Article

References (24)

1. Rogers, S., McIntosh, R.L., Cheung, N., Lim, L., Wang, J.J., Mitchell, P., Kowalski, J.W., Nguyen, H., and Wong, T.Y. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 117:313-319, 2010.
2. Mitchell, P., Smith, W., and Chang, A. Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study. Arch. Ophthalmol. 114:1243-1247, 1996.
3. Rehak, J., and Rehak, M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr. Eye Res. 33:111-131, 2008.
4. Campochiaro, P.A., Hafiz, G., Shah, S.M., Nguyen, Q.D., Ying, H., Do, D.V., Quinlan, E., Zimmer-Galler, I., Haller, J.A., Solomon, S.D., Sung, J.U., Hadi, Y. Janjua, K.A., Jawed, N., Choy, D.F., and Arron, J.R. Ranibizumab for macular edema due to retinal vein occlusions; implication of VEGF as a critical stimulator. Mol. Ther. 16:791-799, 2008.
5. Chen, K.H., Wu, C.C., Roy, S., Lee, S.M., and Liu, J.H. Increased interleukin-6 in aqueous humour of neovascular glaucoma. Invest. Ophthalmol. Vis Sci. 40:2627-2632, 1999.
6. Haller, J.A., Bandello, F., Belfort, R., Jr., Blumenkranz, M.S., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y.H., Jacques, M.L., Jiao, J., Li, X.Y., and Whitcup, S.M. Ozurdex Geneva Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 117:1134-1146, 2010.
7. Haller, J.A., Bandello, F., Belfort, R., Jr., Blumenkranz, M.S., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y.H., Jacques, M.L., Jiao, J., Li, X.Y., and Whitcup, S.M. Ozurdex Geneva study group.Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion. Ophthalmology. 118:2453-2460, 2011.
8. Lowder, C., Belfort, R., Jr., Lightman, S., Foster, C.S., Robinson, M.R., Schiffman, R.M., Li, X.Y., Cui, H., and Whitcup, S.M., Ozurdex HURON Study Group. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch. Ophthalmol. 129:545-553, 2011.
9. Kuppermann, B.D., Blumenkranz, M.S., Haller, J.A., Williams, G.A., Weinberg, D.V., Chou, C., and Whitcup, S.M. Dexamethasone DDS Phase II Study Group. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch. Ophthalmol. 125:309-317, 2007.
10. Goldmann, H., and Schmitt, T. Applanation tonometry. Ophthalmologica. 134:221-242, 1957.
11. Lanza, M., Borrelli, M., De Bernardo, M., Filosa, M.L., and Rosa, N. Corneal parameters and difference between goldmann applanation tonometry and dynamic contour tonometry in normal eyes. J. Glaucoma. 17:460-464, 2008.
12. Kaufmann, C., Bachmann, L.M., and Thiel, M.A. Comparison of dynamic contour tonometry with goldmann applanation tonometry. Invest. Ophthalmol. Vis Sci. 45:3118-3112, 2004.
13. Kotecha, A., White, E.T., Shewry, J.M., and Garway-Heath, D.F. The relative effects of corneal thickness and age on Goldmann applanation tonometry and dynamic contour tonometry. Br. J. Ophthalmol. 89:1572-1575, 2005.
14. Francis, B.A., Hsieh, A., Lai, M.Y., Chopra, V., Pena, F., Azen, S., and Varma, R. Effects of corneal thickness, corneal curvature, and intraocular pressure level on Goldmann applanation tonometry and dynamic contour tonometry. Ophthalmology. 114:20-26, 2007.
15. Mangouritsas, G., Mourtzoukos, S., Mantzounis, A., and Alexopoulos, L. Comparison of Goldmann and Pascal tonometry in relation to corneal hysteresis and central corneal thickness in nonglaucomatous eyes. Clin. Ophthalmol. 5:1071-1077, 2011.
16. Pache, M., Wilmsmeyer, S., Lautebach, S., and Funk, J. Dynamic contour tonometry versus Goldmann applanation tonometry: a comparative study. Graefes Arch. Clin. Exp. Ophthalmol. 243:763-767, 2005.
17. Realini, T., Weinreb, R.N., and Hobbs, G. Correlation of intraocular pressure measured with goldmann and dynamic contour tonometry in normal and glaucomatous eyes. J. Glaucoma. 18:119-123, 2009.
18. Halkiadakis, I., Patsea, E., Chatzimichali, K., Skouriotis, S., Chalkidou, S., Amariotakis, G., Papakonstadinou, D., Theodossiadis, G., Amariotakis, A., and Georgopoulos, G. Comparison of dynamic contour tonometry with Goldmann applanation tonometry in glaucoma practice. Acta Ophthalmol. 87:323-328, 2009.
19. Doyle, A., and Lachkar, Y. Comparison of dynamic contour tonometry with goldman applanation tonometry over a wide range of central corneal thickness. J. Glaucoma. 14:288- 292, 2005.
20. Ip, M.S., Scott, I.U., VanVeldhuise, P.C., Oden, N.L., Blodi, B.A., Fisher, M., Singerman, L.J., Tolentino, M., Chan, C.K., and Gonzalez, V.H.; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch. Ophthalmol. 127:1101-1114, 2009 Erratum in: Arch. Ophthalmol. 127:1648.
21. Scott, I.U., Ip, M.S., VanVeldhuisen, P.C., Oden, N.L., Blodi, B.A., Fisher, M., Chan, C.K., Gonzalez, V.H., Singerman, L.J., and Tolentino, M.; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch. Ophthalmol. 127:1115-1128, 2009 Erratum in: Arch Ophthalmol 12:1655.
22. Jones, R., 3rd, and Rhee. D.J. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr. Opin. Ophthalmol. 17:163-167, 2006.
23. Kersey, J.P., and Broadway, D.C. Corticosteroid-induced glaucoma: a review of the literature. Eye. 20:407-416, 2006.
24. Zhuo, Y., He, Y., Leung, K., Hou, F., Li, Y.Q., Chai, F., and Ge, J. Dexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells. Mol. Vis. 16:61-71, 2010.